Publications

Search ACTG publications from 1/1/2006 to current.

Search

Filter results by

Found 39 results
Filters: First Letter Of Last Name is R  [Clear All Filters]
Found 39 results.
Skip Alphabet Links A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

R

Robertson K, Oladeji B, Jiang H, et al. "HIV-1 and TB Co-infection in Multinational Resource Limited Settings: Increased neurological dysfunction." Clin. Infect. Dis.. 2018.
Rockwood N, Meintjes G, Chirehwa M, et al. "HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients." Antimicrob. Agents Chemother.. 2016;60(10):6050-9.
Rodriguez B, Lederman MM, Jiang W, et al. "Interferon-alpha differentially rescues CD4 and CD8 T cells from apoptosis in HIV infection." AIDS. 2006;20(10):1379-89.
Rodriguez B, Asmuth DM, Matining RM, et al. "Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial." J. Acquir. Immune Defic. Syndr.. 2013;64(4):351-9.
F Romo T, Smeaton LM, Campbell TB, et al. "Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: a focused safety analysis of ACTG PEARLS (A5175)." HIV Clin Trials. 2014;15(6):246-60.
Rosenberg ES, Graham BS, Chan ES, et al. "Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection." PLoS ONE. 2010;5(5):e10555.
Rosenkranz SL, Yarasheski KE, Para MF, Reichman RC, Morse GD. "Antiretroviral Drug Levels and Interactions Affect Lipid, Lipoprotein, and Glucose Metabolism in HIV-1 Seronegative Subjects: A Pharmacokinetic-Pharmacodynamic Analysis." Metab Syndr Relat Disord. 2007;5(2):163-73.
Rouabhia M, Semlali A, Chandra J, Mukherjee P, Chmielewski W, Ghannoum MA. "Disruption of the ECM33 gene in Candida albicans prevents biofilm formation, engineered human oral mucosa tissue damage and gingival cell necrosis/apoptosis." Mediators Inflamm.. 2012;2012:398207.
Rutstein SE, Hosseinipour MC, Weinberger M, et al. "Predicting resistance as indicator for need to switch from first-line antiretroviral therapy among patients with elevated viral loads: development of a risk score algorithm." BMC Infect. Dis.. 2016;16(1):280.

Pages